BRCA1 and digestive system neoplasm: The great majority of gastrointestinal tumor cell lines used in this study harbor BRCA1/2 heterozygous mutations; the exception is HGC-27, which harbors homozygous BRCA2p.F2058L mutation (Fig. S2a)45.